; and (B) require public, in-person hearings. (2) Publication of information The Secretary shall publish on the website of the Food and Drug Administration the transcripts of all hearings conducted pursuant to paragraph (1)(B), subject to section 552(b) of title 5, United States Code. (e) Import alert requirements The Secretary may not issue, implement, or enforce an import alert for a kratom or kratom-derived product unless the Secretary determines that there is a history of such kratom or kratom-derived product being adulterated as described in section 402(f)(1)(A) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 342(f)(1)(A) ), or evidence that such kratom or kratom-derived product is adulterated as described in such section. (f) Nonpreemption Nothing in this section shall preempt any State law. (g) Definitions In this section: (1) Secretary The term Secretary means the Secretary of Health and Human Services. (2) Commissioner The term Commissioner means the Commissioner of Food and Drugs. (3) Dietary supplement The term dietary supplement has the meaning given such term in section 201(ff) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(ff) ). (4) Dietary ingredient The term dietary ingredient means a dietary ingredient as such term is used in section 201(ff)(1) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(ff)(1) ). (5) Food The term food has the meaning given such term in section 201(f) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(f) ). (6) Kratom – The term kratom means the botanical Mitragyna speciosa. (7) New dietary ingredient The term new dietary ingredient has the meaning given such term in section 413(d) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 350b(d) ).